IPP REVENUE HITS

Friday, December 14, 2012

Dabigartan a Better Blood Thinner

Likely to be available into market in 2 to 3 years from now, Dabigartan an oral blood thinner drug has big potential to outweigh warfarin as a drug of choice for stroke. It is seen that high dose of this drug can work better than that of warfarin at preventing stroke and CVA. It is known at lower dose seems to be a good and is less to cause side effects. 

Mobile footer